ArticleFoods (Basel, Switzerland)2025
Nature's Preservative: Epigallocatechin Gallate-Loaded Edible Film Extends Mango Shelf Life.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To reduce the environmental impact of plastic packaging in the fruit supply chain, this study developed an edible natural CH-CS-EGCG coating (collagen hydrolysate-chitosan-epigallocatechin gallate) for mango preservation. The coating was prepared using an optimized CH:CS mass ratio of 1:4 with 3 wt% EGCG, exhibiting enhanced mechanical properties and low water vapor permeability. SEM and FT-IR analyses confirmed the successful incorporation of EGCG into the CH-CS matrix through hydrogen bonding, hydrophobic interactions, and electrostatic forces. The CH-CS-EGCG coating demonstrated superior antioxidant activity: its ABTS radical scavenging capacity and DPPH scavenging capacity were 234% and 422% higher, respectively, than those of the CH-CS coating. It also effectively inhibited bacterial growth, achieving a 92% inhibition rate against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.